Benchmark Research CEO, Mark Lacy, Listed as One of 50 “Most Influential People in Vaccines” in the 2014 Vaccine Nation Survey

Share Article

Mark Lacy, Founder and CEO of Benchmark Research, has been honored as being one of 50 “Most Influential People in Vaccines.”

Mark Lacy, CEO of Benchmark Research

To be recognized and honored with this award justifies our belief in the exceptional quality of our Benchmark Research team.

Mark Lacy, Founder and CEO of Benchmark Research, has been named one of the 50 “Most Influential People in Vaccines” as chosen by readers of Vaccine Nation. The 50 representatives were selected based on the strength of their career achievements or the inspiration they provide to others in the industry. Mr. Lacy is the only one of the 50 vaccine leaders to represent the investigative site segment of the industry, and the first site leader chosen.

“Scott and I could not be more proud of our Benchmark family. The dedication and commitment that they display is evidenced by the groundbreaking results of the vaccine studies they conduct, and to be recognized and honored once again with this award justifies our belief in the exceptional quality of our Benchmark Research team,” said Lacy.

Benchmark Research is a geographically diverse, integrated site network comprised of six dedicated, multi-therapeutic research centers that specialize in vaccine research. Quality is paramount at Benchmark, something that has been noted by their peers, as they have been named Best Clinical Site and/or Network at the World Vaccine Congress’ Vaccine Industry Excellence awards every year since the event’s inception.

Benchmark continues to both expand and innovate in their quest to maintain their standing as the leading site network in the vaccine clinical research industry.

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Richard Kahn
Visit website